BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36320043)

  • 1. A Δ42PD1 fusion-expressing DNA vaccine elicits enhanced adaptive immune response to HIV-1: the key role of TLR4.
    Cheng L; Tang X; He Y; Ju B; Wang H
    Virol J; 2022 Nov; 19(1):174. PubMed ID: 36320043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiating functional antigen-specific CD8⁺ T cell immunity by a novel PD1 isoform-based fusion DNA vaccine.
    Zhou J; Cheung AK; Liu H; Tan Z; Tang X; Kang Y; Du Y; Wang H; Liu L; Chen Z
    Mol Ther; 2013 Jul; 21(7):1445-55. PubMed ID: 23587922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice.
    Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L
    J Virol; 2021 May; 95(12):. PubMed ID: 33789991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes.
    Abdel-Motal UM; Wang S; Awad A; Lu S; Wigglesworth K; Galili U
    Vaccine; 2010 Feb; 28(7):1758-65. PubMed ID: 20034607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
    Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
    Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine.
    Kim BJ; Kim BR; Kook YH; Kim BJ
    Front Immunol; 2018; 9():643. PubMed ID: 29636755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice.
    Zhou J; Cheung AK; Tan Z; Wang H; Yu W; Du Y; Kang Y; Lu X; Liu L; Yuen KY; Chen Z
    J Clin Invest; 2013 Jun; 123(6):2629-42. PubMed ID: 23635778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine.
    Sadat Larijani M; Ramezani A; Mashhadi Abolghasem Shirazi M; Bolhassani A; Pouriayevali MH; Shahbazi S; Sadat SM
    Virus Res; 2021 Jun; 298():198403. PubMed ID: 33775753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut-homing Δ42PD1
    Cheung AKL; Kwok HY; Huang Y; Chen M; Mo Y; Wu X; Lam KS; Kong HK; Lau TCK; Zhou J; Li J; Cheng L; Kiat Lee B; Peng Q; Lu X; An M; Wang H; Shang H; Zhou B; Wu H; Xu A; Yuen KY; Chen Z
    Nat Microbiol; 2017 Oct; 2(10):1389-1402. PubMed ID: 28808299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.
    Flynn BJ; Kastenmüller K; Wille-Reece U; Tomaras GD; Alam M; Lindsay RW; Salazar AM; Perdiguero B; Gomez CE; Wagner R; Esteban M; Park CG; Trumpfheller C; Keler T; Pantaleo G; Steinman RM; Seder R
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7131-6. PubMed ID: 21467219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin-minimized HIV-1 p24 fused to murine hsp70 activates dendritic cells, facilitates endocytosis and p24-specific Th1 response in mice.
    Krupka M; Zachova K; Cahlikova R; Vrbkova J; Novak Z; Sebela M; Weigl E; Raska M
    Immunol Lett; 2015 Jul; 166(1):36-44. PubMed ID: 26021827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.
    Idoyaga J; Lubkin A; Fiorese C; Lahoud MH; Caminschi I; Huang Y; Rodriguez A; Clausen BE; Park CG; Trumpfheller C; Steinman RM
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2384-9. PubMed ID: 21262813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.
    Climent N; Munier S; Piqué N; García F; Pavot V; Primard C; Casanova V; Gatell JM; Verrier B; Gallart T
    Vaccine; 2014 Oct; 32(47):6266-76. PubMed ID: 25240755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.
    Trumpfheller C; Finke JS; López CB; Moran TM; Moltedo B; Soares H; Huang Y; Schlesinger SJ; Park CG; Nussenzweig MC; Granelli-Piperno A; Steinman RM
    J Exp Med; 2006 Mar; 203(3):607-17. PubMed ID: 16505141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.
    Kulkarni V; Rosati M; Valentin A; Ganneru B; Singh AK; Yan J; Rolland M; Alicea C; Beach RK; Zhang GM; Le Gall S; Broderick KE; Sardesai NY; Heckerman D; Mothe B; Brander C; Weiner DB; Mullins JI; Pavlakis GN; Felber BK
    PLoS One; 2013; 8(3):e60245. PubMed ID: 23555935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody.
    Cheong C; Choi JH; Vitale L; He LZ; Trumpfheller C; Bozzacco L; Do Y; Nchinda G; Park SH; Dandamudi DB; Shrestha E; Pack M; Lee HW; Keler T; Steinman RM; Park CG
    Blood; 2010 Nov; 116(19):3828-38. PubMed ID: 20668230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development.
    Franco D; Li W; Qing F; Stoyanov CT; Moran T; Rice CM; Ho DD
    Vaccine; 2010 Aug; 28(35):5676-85. PubMed ID: 20600494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies specific to human Δ42PD1: A novel immunoregulator potentially involved in HIV-1 and tumor pathogenesis.
    Cheng L; Tang X; Liu L; Peng J; Nishiura K; Cheung AK; Guo J; Wu X; Tang HY; An M; Zhou J; Cheung KW; Wang H; Guan X; Wu Z; Chen Z
    MAbs; 2015; 7(3):620-9. PubMed ID: 25692916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.